Lorenzo Pilla

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

Paola Filipazzi, Roberta Valenti, Veronica Huber et al. · Journal of Clinical Oncology · 2007 · 639 citations

Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes

Roberta Valenti, Veronica Huber, Paola Filipazzi et al. · Cancer Research · 2006 · 479 citations · Full text

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

Filiberto Belli, Alessandro Testori, Licia Rivoltini et al. · Journal of Clinical Oncology · 2002 · 385 citations

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

Anna Maria Di Giacomo, Paolo A. Ascierto, Lorenzo Pilla et al. · The Lancet Oncology · 2012 · 280 citations

Oncology, Single-arm Phase 2, Melanoma +6

IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells

Cristina Tecchio, Veronica Huber, Patrizia Scapini et al. · Blood · 2004 · 158 citations · Full text